Hypoxia-induced RBBP7 promotes esophagus cancer progression by inducing CDK4 expression: RBBP7 promotes esophagus cancer progression

por Wang, Renfeng, Huang, Zhiliang, Lin, Zhenyang, Chen, Borong, Pang, Xuguang, Du, Chaoxiang, Fan, Hong
Publicado 2022

Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial

por Yin, Jun, Yuan, Jingnan, Li, Yunjin, Fang, Yong, Wang, Ruoxi, Jiao, Heng, Tang, Han, Zhang, Shaoyuan, Lin, Siyun, Su, Feng, Gu, Jianmin, Jiang, Tian, Lin, Dong, Huang, Zhiliang, Du, Chaoxiang, Wu, Kui, Tan, Lijie, Zhou, Qing
Publicado 2023

Publisher Correction: Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial

por Yin, Jun, Yuan, Jingnan, Li, Yunjin, Fang, Yong, Wang, Ruoxi, Jiao, Heng, Tang, Han, Zhang, Shaoyuan, Lin, Siyun, Su, Feng, Gu, Jianmin, Jiang, Tian, Lin, Dong, Huang, Zhiliang, Du, Chaoxiang, Wu, Kui, Tan, Lijie, Zhou, Qing
Publicado 2023